{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:44:46Z","timestamp":1791416686892,"version":"4.3.3"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00467-021-04936-w","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T15:08:49Z","timestamp":1612364929000},"page":"3813-3827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Muscle-bone axis in children with chronic kidney disease: current knowledge and future perspectives"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3638-5179","authenticated-orcid":false,"given":"Vasiliki","family":"Karava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Christoforidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Kondou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoleta","family":"Printza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"key":"4936_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bone.2015.02.010","volume":"80","author":"M Brotto","year":"2005","unstructured":"Brotto M, Bonewald L (2005) Bone and muscle: interactions beyond mechanical. Bone 80:109\u2013114","journal-title":"Bone"},{"key":"4936_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6065\/apem.2017.22.1.1","volume":"22","author":"C Maggioli","year":"2017","unstructured":"Maggioli C, Stagi S (2017) Bone modeling, remodeling, and skeletal health in children and adolescents: mineral accrual, assessment and treatment. Ann Pediatr Endocrinol Metab 22:1\u20135","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"4936_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00223-016-0183-x","volume":"99","author":"I Sioen","year":"2016","unstructured":"Sioen I, Lust E, De Henauw S, Moreno LA, Jim\u00e9nez-Pav\u00f3n D (2016) Associations between body composition and bone health in children and adolescents: a systematic review. Calcif Tissue Int 99:557\u2013577","journal-title":"Calcif Tissue Int"},{"key":"4936_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1365-2796.1994.tb00814.x","volume":"236","author":"JO Kristinsson","year":"1994","unstructured":"Kristinsson JO, Valdimarsson O, Steingrimsdottir L, Sigurdsson G (1994) Relation between calcium intake, grip strength and bone mineral density in the forearms of girls aged 13 and 15. J Intern Med 236:385\u2013390","journal-title":"J Intern Med"},{"key":"4936_CR5","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00198-008-0595-1","volume":"19","author":"DC Chan","year":"2008","unstructured":"Chan DC, Lee WT, Lo DH, Leung JC, Kwok AW, Leung PC (2008) Relationship between grip strength and bone mineral density in healthy Hong Kong adolescents. Osteoporos Int 19:1485\u20131495","journal-title":"Osteoporos Int"},{"key":"4936_CR6","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.bone.2004.01.022","volume":"34","author":"F Rauch","year":"2004","unstructured":"Rauch F, Bailey DA, Baxter-Jones A, Mirwald R, Faulkner R (2004) The 'muscle-bone unit' during the pubertal growth spurt. Bone 34:771\u2013775","journal-title":"Bone"},{"key":"4936_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12020-013-0026-8","volume":"45","author":"L Cianferotti","year":"2014","unstructured":"Cianferotti L, Brandi ML (2014) Muscle-bone interactions: basic and clinical aspects. Endocrine 45:165\u2013177","journal-title":"Endocrine"},{"key":"4936_CR8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1515\/JPEM.2000.13.6.571","volume":"13","author":"HM Frost","year":"2000","unstructured":"Frost HM, Schoenau E (2000) The \"muscle-bone unit\" in children and adolescents: a 2000 overview. J Pediatr Endocrinol Metab 13:571\u2013590","journal-title":"J Pediatr Endocrinol Metab"},{"key":"4936_CR9","first-page":"232","volume":"5","author":"E Schoenau","year":"2005","unstructured":"Schoenau E (2005) From mechanostat theory to development of the \"functional muscle-bone-unit\". J Musculoskelet Neuronal Interact 5:232\u2013238","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"4936_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.11005\/jbm.2014.21.1.29","volume":"21","author":"H Kaji","year":"2014","unstructured":"Kaji H (2014) Interaction between muscle and bone. J Bone Metab 21:29\u201340","journal-title":"J Bone Metab"},{"key":"4936_CR11","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.2215\/CJN.01330210","volume":"5","author":"SA Bakkaloglu","year":"2010","unstructured":"Bakkaloglu SA, Wesseling-Perry K, Pereira RC, Gales B, Wang HJ, Elashoff RM, Salusky IB (2010) Value of the new bone classification system in pediatric renal osteodystrophy. Clin J Am Soc Nephrol 5:1860\u20131866","journal-title":"Clin J Am Soc Nephrol"},{"key":"4936_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2215\/CJN.05940611","volume":"7","author":"K Wesseling-Perry","year":"2012","unstructured":"Wesseling-Perry K, Pereira RC, Tseng CH, Elashoff R, Zaritsky JJ, Yadin O, Sahney S, Gales B, J\u00fcppner H, Salusky IB (2012) Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol 7:146\u2013152","journal-title":"Clin J Am Soc Nephrol"},{"key":"4936_CR13","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1210\/jc.2012-4188","volume":"98","author":"MR Denburg","year":"2013","unstructured":"Denburg MR, Tsampalieros AK, de Boer IH, Shults J, Kalkwarf HJ, Zemel BS, Foerster D, Stokes D, Leonard MB (2013) Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease. J Clin Endocrinol Metab 98:1930\u20131938","journal-title":"J Clin Endocrinol Metab"},{"key":"4936_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nrneph.2014.112","volume":"10","author":"XH Wang","year":"2014","unstructured":"Wang XH, Mitch WE (2014) Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol 10:504\u2013516","journal-title":"Nat Rev Nephrol"},{"key":"4936_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1681\/ASN.2010060603","volume":"22","author":"BJ Foster","year":"2011","unstructured":"Foster BJ, Kalkwarf HJ, Shults J, Zemel BS, Wetzsteon RJ, Thayu M, Foerster DL, Leonard MB (2011) Association of chronic kidney disease with muscle deficits in children. J Am Soc Nephrol 22:377\u2013386","journal-title":"J Am Soc Nephrol"},{"key":"4936_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00467-019-04461-x","volume":"35","author":"J Hogan","year":"2020","unstructured":"Hogan J, Schneider MF, Pai R, Denburg MR, Kogon A, Brooks ER, Kaskel FJ, Reidy KJ, Saland JM, Warady BA, Furth SL, Patzer RE, Greenbaum LA (2020) Grip strength in children with chronic kidney disease. Pediatr Nephrol 35:891\u2013899","journal-title":"Pediatr Nephrol"},{"key":"4936_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/agm2.12080","volume":"2","author":"B Kirk","year":"2019","unstructured":"Kirk B, Al Saedi A, Duque G (2019) Osteosarcopenia: a case of geroscience. Aging Med (Milton) 2:147\u2013156","journal-title":"Aging Med (Milton)"},{"key":"4936_CR18","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s00467-019-04313-8","volume":"34","author":"K Sgambat","year":"2019","unstructured":"Sgambat K, Matheson MB, Hooper SR, Warady B, Furth S, Moudgil A (2019) Prevalence and outcomes of fragility: a frailty-inflammation phenotype in children with chronic kidney disease. Pediatr Nephrol 34:2563\u20132569","journal-title":"Pediatr Nephrol"},{"key":"4936_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12891-017-1403-x","volume":"18","author":"G Li","year":"2017","unstructured":"Li G, Thabane L, Papaioannou A, Ioannidis G, Levine MA, Adachi JD (2017) An overview of osteoporosis and frailty in the elderly. BMC Musculoskelet Disord 18:46","journal-title":"BMC Musculoskelet Disord"},{"key":"4936_CR20","doi-asserted-by":"publisher","unstructured":"Karava V, Dotis J, Christoforidis A, Liakopoulos V, Kondou A, Tsigaras G, Tsioni K, Kollios K, Printza N (2021) Association between insulin growth factor-1, bone mineral density and frailty phenotype in children with chronic kidney disease. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-021-04918-y","DOI":"10.1007\/s00467-021-04918-y"},{"key":"4936_CR21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00467-009-1427-z","volume":"25","author":"WW Cheung","year":"2010","unstructured":"Cheung WW, Paik KH, Mak RH (2010) Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol 25:711\u2013724","journal-title":"Pediatr Nephrol"},{"key":"4936_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1677\/JOE-08-0568","volume":"201","author":"R Hardy","year":"2009","unstructured":"Hardy R, Cooper MS (2009) Bone loss in inflammatory disorders. J Endocrinol 201:309\u2013320","journal-title":"J Endocrinol"},{"key":"4936_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cca.2020.03.040","volume":"506","author":"S Mazzaferro","year":"2020","unstructured":"Mazzaferro S, De Martini N, Rotondi S, Tartaglione L, Ure\u00f1a-Torres P, Bover J, Pasquali M, ERA-EDTA Working Group on CKD-MBD (2020) Bone, inflammation and chronic kidney disease. Clin Chim Acta 506:236\u2013240","journal-title":"Clin Chim Acta"},{"key":"4936_CR24","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/sj.ki.5000311","volume":"69","author":"FC Barreto","year":"2006","unstructured":"Barreto FC, Barreto DV, Moyses RM, Neves CL, Jorgetti V, Draibe SA, Canziani ME, Carvalho AB (2006) Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem. Kidney Int 69:1852\u20131857","journal-title":"Kidney Int"},{"key":"4936_CR25","first-page":"783","volume":"22","author":"A Ferreira","year":"2009","unstructured":"Ferreira A, Saraiva M, Behets G, Macedo A, Galv\u00e3o M, D'Haese P, Dr\u00fceke TB (2009) Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry. J Nephrol 22:783\u2013793","journal-title":"J Nephrol"},{"key":"4936_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1053\/j.ackd.2019.09.006","volume":"26","author":"P Evenepoel","year":"2019","unstructured":"Evenepoel P, Opdebeeck B, David K, D\u2019Haese PC (2019) Bone-vascular axis in chronic kidney disease. Adv Chronic Kidney Dis 26:472\u2013483","journal-title":"Adv Chronic Kidney Dis"},{"key":"4936_CR27","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1038\/sj.ki.5001969","volume":"70","author":"CM Avesani","year":"2006","unstructured":"Avesani CM, Carrero JJ, Axelsson J, Qureshi AR, Lindholm B, Stenvinkel P (2006) Inflammation and wasting in chronic kidney disease: partners in crime. Kidney Int 70:S8\u2013S13","journal-title":"Kidney Int"},{"key":"4936_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00467-004-1789-1","volume":"20","author":"RH Mak","year":"2005","unstructured":"Mak RH, Cheung W, Cone RD, Marks DL (2005) Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease. Pediatr Nephrol 20:427\u2013431","journal-title":"Pediatr Nephrol"},{"key":"4936_CR29","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00467-010-1733-5","volume":"26","author":"WW Cheung","year":"2011","unstructured":"Cheung WW, Zhan JY, Paik KH, Mak RH (2011) The impact of inflammation on bone mass in children. Pediatr Nephrol 26:1937\u20131946","journal-title":"Pediatr Nephrol"},{"key":"4936_CR30","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2006.10.008","volume":"4","author":"G Karsenty","year":"2006","unstructured":"Karsenty G (2006) Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 4:341\u2013348","journal-title":"Cell Metab"},{"key":"4936_CR31","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1053\/j.jrn.2010.07.005","volume":"21","author":"Y Oner-Iyidogan","year":"2011","unstructured":"Oner-Iyidogan Y, Gurdol F, Kocak H, Oner P, Cetinalp-Demircan P, Caliskan Y, Kocak T, Turkmen A (2011) Appetite-regulating hormones in chronic kidney disease patients. J Ren Nutr 21:316\u2013321","journal-title":"J Ren Nutr"},{"key":"4936_CR32","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1681\/ASN.V961074","volume":"9","author":"M Daschner","year":"1998","unstructured":"Daschner M, T\u00f6nshoff B, Blum WF, Englaro P, Wingen AM, Schaefer F, W\u00fchl E, Rascher W, Mehls O (1998) Inappropriate elevation of serum leptin levels in children with chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Am Soc Nephrol 9:1074\u20131079","journal-title":"J Am Soc Nephrol"},{"key":"4936_CR33","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00467-017-3840-z","volume":"33","author":"A Monzani","year":"2018","unstructured":"Monzani A, Perrone M, Prodam F, Moia S, Genoni G, Testa S, Paglialonga F, Rapa A, Bona G, Montini G, Edefonti A (2018) Unacylated ghrelin and obestatin: promising biomarkers of protein energy wasting in children with chronic kidney disease. Pediatr Nephrol 33:661\u2013672","journal-title":"Pediatr Nephrol"},{"key":"4936_CR34","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s11255-013-0623-8","volume":"46","author":"J Zhang","year":"2014","unstructured":"Zhang J, Wang N (2014) Leptin in chronic kidney disease: a link between hematopoiesis, bone metabolism, and nutrition. Int Urol Nephrol 46:1169\u20131174","journal-title":"Int Urol Nephrol"},{"key":"4936_CR35","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/jcsm.12218","volume":"8","author":"P Molina","year":"2017","unstructured":"Molina P, Carrero JJ, Bover J, Chauveau P, Mazzaferro S, Torres PU (2017) Vitamin D, a modulator of musculoskeletal health in chronic kidney disease. J Cachexia Sarcopenia Muscle 8:686\u2013701","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4936_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5414\/CN107160","volume":"76","author":"H Taskapan","year":"2011","unstructured":"Taskapan H, Baysal O, Karahan D, Durmus B, Altay Z, Ulutas O (2011) Vitamin D and muscle strength, functional ability and balance in peritoneal dialysis patients with vitamin D deficiency. Clin Nephrol 76:110\u2013116","journal-title":"Clin Nephrol"},{"key":"4936_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1053\/j.jrn.2011.10.006","volume":"22","author":"PL Gordon","year":"2012","unstructured":"Gordon PL, Doyle JW, Johansen KL (2012) Association of 1,25-dihydroxyvitamin D levels with physical performance and thigh muscle cross-sectional area in chronic kidney disease stage 3 and 4. J Ren Nutr 22:423\u2013433","journal-title":"J Ren Nutr"},{"key":"4936_CR38","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1172\/JCI110936","volume":"71","author":"AJ Garber","year":"1983","unstructured":"Garber AJ (1983) Effects of parathyroid hormone on skeletal muscle protein and amino acid metabolism in the rat. J Clin Invest 71:1806\u20131821","journal-title":"J Clin Invest"},{"key":"4936_CR39","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ki.1985.190","volume":"28","author":"R Baczynski","year":"1985","unstructured":"Baczynski R, Massry SG, Magott M, el-Belbessi S, Kohan R, Brautbar N (1985) Effect of parathyroid hormone on energy metabolism of skeletal muscle. Kidney Int 28:722\u2013727","journal-title":"Kidney Int"},{"key":"4936_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cmet.2015.11.003","volume":"23","author":"S Kir","year":"2016","unstructured":"Kir S, Komaba H, Garcia AP, Economopoulos KP, Liu W, Lanske B, Hodin RA, Spiegelman BM (2016) PTH\/PTHrP receptor mediates cachexia in models of kidney failure and cancer. Cell Metab 23:315\u2013323","journal-title":"Cell Metab"},{"key":"4936_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1073-4449(12)80070-7","volume":"2","author":"JA Kraut","year":"1995","unstructured":"Kraut JA (1995) The role of metabolic acidosis in the pathogenesis of renal osteodystrophy. Adv Ren Replace Ther 2:40\u201351","journal-title":"Adv Ren Replace Ther"},{"key":"4936_CR42","first-page":"398","volume":"21","author":"KC Lu","year":"1995","unstructured":"Lu KC, Lin SH, Yu FC, Chyr SH, Shieh SD (1995) Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure. Miner Electrolyte Metab 21:398\u2013402","journal-title":"Miner Electrolyte Metab"},{"key":"4936_CR43","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1046\/j.1523-1755.2003.08802.x","volume":"88","author":"R Mehrotra","year":"2003","unstructured":"Mehrotra R, Kopple JD, Wolfson M (2003) Metabolic acidosis in maintenance dialysis patients: clinical considerations. Kidney Int Suppl 88:S13\u2013S25","journal-title":"Kidney Int Suppl"},{"key":"4936_CR44","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/PL00013425","volume":"14","author":"FA Ord\u00f3\u00f1ez","year":"2000","unstructured":"Ord\u00f3\u00f1ez FA, Santos F, Mart\u00ednez V, Garc\u00eda E, Fern\u00e1ndez P, Rodr\u00edguez J, Fern\u00e1ndez M, Alvarez J, Ferrando S (2000) Resistance to growth hormone and insulin-like growth factor-I in acidotic rats. Pediatr Nephrol 14:720\u2013725","journal-title":"Pediatr Nephrol"},{"key":"4936_CR45","first-page":"375","volume":"21","author":"G Coen","year":"1995","unstructured":"Coen G, Manni M, Addari O, Ballanti P, Pasquali M, Chicca S, Mazzaferro S, Napoletano I, Sardella D, Bonucci E (1995) Metabolic acidosis and osteodystrophic bone disease in predialysis chronic renal failure: effect of calcitriol treatment. Miner Electrolyte Metab 21:375\u2013382","journal-title":"Miner Electrolyte Metab"},{"key":"4936_CR46","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/oxfordjournals.ndt.a027404","volume":"11","author":"G Coen","year":"1996","unstructured":"Coen G, Mazzaferro S, Ballanti P, Sardella D, Chicca S, Manni M, Bonucci E, Taggi F (1996) Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. Nephrol Dial Transplant 11:813\u2013819","journal-title":"Nephrol Dial Transplant"},{"key":"4936_CR47","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1046\/j.1523-1755.2001.0590031086.x","volume":"59","author":"S Domrongkitchaiporn","year":"2001","unstructured":"Domrongkitchaiporn S, Pongsakul C, Stitchantrakul W, Sirikulchayanonta V, Ongphiphadhanakul B, Radinahamed P, Karnsombut P, Kunkitti N, Ruang-raksa C, Rajatanavin R (2001) Bone mineral density and histology in distal renal tubular acidosis. Kidney Int 59:1086\u20131093","journal-title":"Kidney Int"},{"key":"4936_CR48","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1172\/JCI118566","volume":"97","author":"JL Bailey","year":"1996","unstructured":"Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE (1996) The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 97:1447\u20131453","journal-title":"J Clin Invest"},{"key":"4936_CR49","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/ndt\/13.7.1723","volume":"13","author":"VS Lim","year":"1998","unstructured":"Lim VS, Yarasheski KE, Flanigan MJ (1998) The effect of uraemia, acidosis, and dialysis treatment on protein metabolism: a longitudinal leucine kinetic study. Nephrol Dial Transplant 13:1723\u20131730","journal-title":"Nephrol Dial Transplant"},{"key":"4936_CR50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1046\/j.1523-1755.2000.00158.x","volume":"58","author":"Y Boirie","year":"2000","unstructured":"Boirie Y, Broyer M, Gagnadoux MF, Niaudet P, Bresson JL (2000) Alterations of protein metabolism by metabolic acidosis in children with chronic renal failure. Kidney Int 58:236\u2013241","journal-title":"Kidney Int"},{"key":"4936_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bone.2015.04.036","volume":"80","author":"DD Bikle","year":"2015","unstructured":"Bikle DD, Tahimic C, Chang W, Wang Y, Philippou A, Barton ER (2015) Role of IGF-I signaling in muscle bone interactions. Bone 80:79\u201388","journal-title":"Bone"},{"key":"4936_CR52","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2215\/CJN.02470213","volume":"9","author":"T Jia","year":"2014","unstructured":"Jia T, Gama Axelsson T, Heimb\u00fcrger O, B\u00e1r\u00e1ny P, Lindholm B, Stenvinkel P, Qureshi AR (2014) IGF-1 and survival in ESRD. Clin J Am Soc Nephrol 9:120\u2013127","journal-title":"Clin J Am Soc Nephrol"},{"key":"4936_CR53","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5301\/jn.5000185","volume":"26","author":"SH Park","year":"2013","unstructured":"Park SH, Jia T, Qureshi AR, B\u00e1r\u00e1ny P, Heimb\u00fcrger O, Larsson TE, Axelsson J, Stenvinkel P, Lindholm B (2013) Determinants and survival implications of low bone mineral density in end-stage renal disease patients. J Nephrol 26:485\u2013494","journal-title":"J Nephrol"},{"key":"4936_CR54","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1046\/j.1523-1755.1998.00812.x","volume":"53","author":"AR Qureshi","year":"1998","unstructured":"Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B, Bergstr\u00f6m J (1998) Factors predicting malnutrition in hemodialysis patients: a cross- sectional study. Kidney Int 53:773\u2013782","journal-title":"Kidney Int"},{"key":"4936_CR55","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s004670000361","volume":"14","author":"T Ulinski","year":"2000","unstructured":"Ulinski T, Mohan S, Kiepe D, Blum WF, Wingen AM, Mehls O, T\u00f6nshoff B (2000) Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure: relationship to growth and glomerular filtration rate. Pediatr Nephrol 14:589\u2013597","journal-title":"Pediatr Nephrol"},{"key":"4936_CR56","doi-asserted-by":"publisher","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","volume":"311","author":"B Spoto","year":"2016","unstructured":"Spoto B, Pisano A, Zoccali C (2016) Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Ren Physiol 311:F1087\u2013F1108","journal-title":"Am J Physiol Ren Physiol"},{"key":"4936_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI20660","volume":"113","author":"DR Clemmons","year":"2004","unstructured":"Clemmons DR (2004) The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J Clin Invest 113:25\u201327","journal-title":"J Clin Invest"},{"key":"4936_CR58","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00592-018-1101-7","volume":"55","author":"C Conte","year":"2018","unstructured":"Conte C, Epstein S, Napoli N (2018) Insulin resistance and bone: a biological partnership. Acta Diabetol 55:305\u2013314","journal-title":"Acta Diabetol"},{"key":"4936_CR59","doi-asserted-by":"publisher","first-page":"E735","DOI":"10.1152\/ajpendo.00159.2005","volume":"289","author":"KM Thrailkill","year":"2005","unstructured":"Thrailkill KM, Lumpkin CK, Bunn RC, Kemp SF, Fowlkes JL (2005) Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 289:E735\u2013E745","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4936_CR60","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/S0168-8227(11)70014-6","volume":"1","author":"G Dimitriadis","year":"2011","unstructured":"Dimitriadis G, Mitron P, Lambadiari V, Maratou E, Raptis SA (2011) Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract Suppl 1:S52\u2013S59","journal-title":"Diabetes Res Clin Pract Suppl"},{"key":"4936_CR61","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1210\/en.2006-0251","volume":"147","author":"X Wang","year":"2006","unstructured":"Wang X, Hu Z, Hu J, Du J, Mitch WE (2006) Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 147:4160\u20134168","journal-title":"Endocrinology"},{"key":"4936_CR62","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/sj.ki.5001984","volume":"71","author":"ED Siew","year":"2007","unstructured":"Siew ED, Pupim LB, Majchrzak KM, Shintani A, Flakoll PJ, Ikizler TA (2007) Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 71:146\u2013152","journal-title":"Kidney Int"},{"key":"4936_CR63","doi-asserted-by":"publisher","unstructured":"Karava V, Dotis J, Kondou A, Christoforidis A, Liakopoulos V, Tsioni K, Kollios K, Papachristou F, Printza N (2020) Association between relative fat mass, uric acid, and insulin resistance in children with chronic kidney disease. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-020-04716-y","DOI":"10.1007\/s00467-020-04716-y"},{"key":"4936_CR64","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/med.21343","volume":"35","author":"C Cabello-Verrugio","year":"2015","unstructured":"Cabello-Verrugio C, Morales MG, Rivera JC, Cabrera D, Simon F (2015) Renin-angiotensin system: an old player with novel functions in skeletal muscle. Med Res Rev 35:437\u2013463","journal-title":"Med Res Rev"},{"key":"4936_CR65","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1249\/JES.0000000000000158","volume":"46","author":"SK Powers","year":"2018","unstructured":"Powers SK, Morton AB, Hyatt H, Hinkley MJ (2018) The renin-angiotensin system and skeletal muscle. Exerc Sport Sci Rev 46:205\u2013214","journal-title":"Exerc Sport Sci Rev"},{"key":"4936_CR66","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/MAJ.0b013e318222e620","volume":"342","author":"S Sukhanov","year":"2011","unstructured":"Sukhanov S, Semprun-Prieto L, Yoshida T, Michael Tabony A, Higashi Y, Galvez S, Delafontaine P (2011) Angiotensin II, oxidative stress and skeletal muscle wasting. Am J Med Sci 342:143\u2013147","journal-title":"Am J Med Sci"},{"key":"4936_CR67","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12018-015-9189-6","volume":"13","author":"J Tamargo","year":"2015","unstructured":"Tamargo J, Caballero R, Delp\u00f3n E (2015) The renin\u2013angiotensin system and bone. Clinic Rev Bone Miner Metab 13:125\u2013148","journal-title":"Clinic Rev Bone Miner Metab"},{"key":"4936_CR68","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1096\/fj.07-098954","volume":"22","author":"H Shimizu","year":"2008","unstructured":"Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R (2008) Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22:2465\u201324751","journal-title":"FASEB J"},{"key":"4936_CR69","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1359\/jbmr.2002.17.6.1095","volume":"17","author":"E Schoenau","year":"2002","unstructured":"Schoenau E, Neu CM, Beck B, Manz F, Rauch F (2002) Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit. J Bone Miner Res 17:1095\u20131101","journal-title":"J Bone Miner Res"},{"key":"4936_CR70","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1111\/j.1523-1755.2004.00937.x","volume":"66","author":"EM Ruth","year":"2004","unstructured":"Ruth EM, Weber LT, Schoenau E, Wunsch R, Seibel MJ, Feneberg R, Mehls O, T\u00f6nshoff B (2004) Analysis of the functional muscle-bone unit of the forearm in pediatric renal transplant recipients. Kidney Int 66:1694\u20131706","journal-title":"Kidney Int"},{"key":"4936_CR71","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ki.2012.347","volume":"83","author":"A Tsampalieros","year":"2013","unstructured":"Tsampalieros A, Kalkwarf HJ, Wetzsteon RJ, Shults J, Zemel BS, Foster BJ, Foerster DL, Leonard MB (2013) Changes in bone structure and the muscle-bone unit in children with chronic kidney disease. Kidney Int 83:495\u2013502","journal-title":"Kidney Int"},{"key":"4936_CR72","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/jbmr.2375","volume":"30","author":"DY Lee","year":"2015","unstructured":"Lee DY, Wetzsteon RJ, Zemel BS, Shults J, Organ JM, Foster BJ, Herskovitz RM, Foerster DL, Leonard MB (2015) Muscle torque relative to cross-sectional area and the functional muscle-bone unit in children and adolescents with chronic disease. J Bone Miner Res 30:563\u2013571","journal-title":"J Bone Miner Res"},{"key":"4936_CR73","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","volume":"96","author":"J Delgado-Calle","year":"2017","unstructured":"Delgado-Calle J, Sato AY, Bellido T (2017) Role and mechanism of action of sclerostin in bone. Bone 96:29\u201337","journal-title":"Bone"},{"key":"4936_CR74","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jbm4.10015","volume":"1","author":"J Huang","year":"2017","unstructured":"Huang J, Romero-Suarez S, Lara N, Mo C, Kaja S, Brotto L, Dallas SL, Johnson ML, J\u00e4hn K, Bonewald LF, Brotto M (2017) Crosstalk between MLO-Y4 osteocytes and C2C12 muscle cells is mediated by the Wnt\/\u03b2-catenin pathway. JBMR Plus 1:86\u2013100","journal-title":"JBMR Plus"},{"key":"4936_CR75","first-page":"C663","volume":"310","author":"SS Dufresne","year":"2016","unstructured":"Dufresne SS, Dumont NA, Boulanger-Piette A, Fajardo VA, Gamu D, Kake-Guena SA, David RO, Bouchard P, Lavergne \u00c9, Penninger JM, Pape PC, Tupling AR, Frenette J (2016) Muscle RANK is a key regulator of Ca2+ storage, SERCA activity, and function of fast-twitch skeletal muscles. Am J Phys Cell Phys 310:C663\u2013C672","journal-title":"Am J Phys Cell Phys"},{"key":"4936_CR76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-018-0533-1","volume":"6","author":"SS Dufresne","year":"2018","unstructured":"Dufresne SS, Boulanger-Piette A, Boss\u00e9 S, Argaw A, Hamoudi D, Marcadet L, Gamu D, Fajardo VA, Yagita H, Penninger JM, Russell Tupling A, Frenette J (2018) Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy. Acta Neuropathol Commun 6:31","journal-title":"Acta Neuropathol Commun"},{"key":"4936_CR77","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/jbmr.1560","volume":"27","author":"R Armamento-Villareal","year":"2012","unstructured":"Armamento-Villareal R, Sadler C, Napoli N, Shah K, Chode S, Sinacore DR, Qualls C, Villareal DT (2012) Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training. J Bone Miner Res 27:1215\u20131221","journal-title":"J Bone Miner Res"},{"key":"4936_CR78","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1074\/jbc.M705092200","volume":"283","author":"AG Robling","year":"2008","unstructured":"Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH (2008) Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost\/sclerostin. J Biol Chem 283:5866\u20135875","journal-title":"J Biol Chem"},{"key":"4936_CR79","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2215\/CJN.07670712","volume":"8","author":"S Pelletier","year":"2013","unstructured":"Pelletier S, Dubourg L, Carlier MC, Hadj-Aissa A, Fouque D (2013) The relation between renal function and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol 8:819\u2013823","journal-title":"Clin J Am Soc Nephrol"},{"key":"4936_CR80","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1093\/ndt\/gfy012","volume":"33","author":"C Lerch","year":"2018","unstructured":"Lerch C, Shroff R, Wan M, Rees L, Aitkenhead H, Kaplan Bulut I, Thurn D, Karabay Bayazit A, Niemirska A, Canpolat N, Duzova A, Azukaitis K, Yilmaz E, Yalcinkaya F, Harambat J, Kiyak A, Alpay H, Habbig S, Zaloszyc A, Soylemezoglu O, Candan C, Rosales A, Melk A, Querfeld U, Leifheit-Nestler M, Sander A, Schaefer F, Haffner D, 4C study consortium, ESPN CKD-MBD working group (2018) Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease. Nephrol Dial Transplant 33:2208\u20132217","journal-title":"Nephrol Dial Transplant"},{"key":"4936_CR81","doi-asserted-by":"publisher","first-page":"e0113482","DOI":"10.1371\/journal.pone.0113482","volume":"10","author":"A Doyon","year":"2015","unstructured":"Doyon A, Fischer DC, Bayazit AK, Canpolat N, Duzova A, S\u00f6zeri B, Bacchetta J, Balat A, B\u00fcscher A, Candan C, Cakar N, Donmez O, Dusek J, Heckel M, Klaus G, Mir S, \u00d6zcelik G, Sever L, Shroff R, Vidal E, W\u00fchl E, Gondan M, Melk A, Querfeld U, Haffner D, Schaefer F, 4C Study Consortium (2015) Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease. PLoS One 10:e0113482","journal-title":"PLoS One"},{"key":"4936_CR82","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1093\/ndt\/gft234","volume":"28","author":"RB de Oliveira","year":"2013","unstructured":"de Oliveira RB, Graciolli FG, dos Reis LM, Cancela AL, Cuppari L, Canziani ME, Carvalho AB, Jorgetti V, Moys\u00e9s RM (2013) Disturbances of Wnt\/\u03b2-catenin pathway and energy metabolism in early CKD: effect of phosphate binders. Nephrol Dial Transplant 28:2510\u20132517","journal-title":"Nephrol Dial Transplant"},{"key":"4936_CR83","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2215\/CJN.06550810","volume":"6","author":"D Cejka","year":"2011","unstructured":"Cejka D, Herberth J, Branscum AJ, Fardo DW, Monier-Faugere MC, Diarra D, Haas M, Malluche HH (2011) Sclerostin and dickkopf-1 in renal osteodystrophy. Clin J Am Soc Nephrol 6:877\u2013882","journal-title":"Clin J Am Soc Nephrol"},{"key":"4936_CR84","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1210\/jc.2014-2372","volume":"99","author":"E Ishimura","year":"2014","unstructured":"Ishimura E, Okuno S, Ichii M, Norimine K, Yamakawa T, Shoji S, Nishizawa Y, Inaba M (2014) Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients. J Clin Endocrinol Metab 99:4315\u20134320","journal-title":"J Clin Endocrinol Metab"},{"key":"4936_CR85","doi-asserted-by":"publisher","first-page":"4596920","DOI":"10.1155\/2020\/4596920","volume":"2020","author":"MC Medeiros","year":"2020","unstructured":"Medeiros MC, Rocha N, Bandeira E, Dantas I, Chaves C, Oliveira M, Bandeira F (2020) Serum sclerostin, body composition, and sarcopenia in hemodialysis patients with diabetes. Int J Nephrol 2020:4596920","journal-title":"Int J Nephrol"},{"key":"4936_CR86","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1053\/j.jrn.2017.04.009","volume":"27","author":"TS Gomes","year":"2017","unstructured":"Gomes TS, Aoike DT, Baria F, Graciolli FG, Moyses RMA, Cuppari L (2017) Effect of aerobic exercise on markers of bone metabolism of overweight and obese patients with chronic kidney disease. J Ren Nutr 27:364\u2013371","journal-title":"J Ren Nutr"},{"key":"4936_CR87","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s40620-014-0092-x","volume":"27","author":"A Monta\u00f1ez-Barrag\u00e1n","year":"2014","unstructured":"Monta\u00f1ez-Barrag\u00e1n A, G\u00f3mez-Barrera I, Sanchez-Ni\u00f1o MD, Ucero AC, Gonz\u00e1lez-Espinoza L, Ortiz A (2014) Osteoprotegerin and kidney disease. J Nephrol 27:607\u2013617","journal-title":"J Nephrol"},{"key":"4936_CR88","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/hmg\/ddz312","volume":"29","author":"D Hamoudi","year":"2020","unstructured":"Hamoudi D, Bouredji Z, Marcadet L, Yagita H, Landry LB, Argaw A, Frenette J (2020) Muscle weakness and selective muscle atrophy in osteoprotegerin-deficient mice. Hum Mol Genet 29:483\u2013494","journal-title":"Hum Mol Genet"},{"key":"4936_CR89","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1093\/ndt\/gfn226","volume":"23","author":"RC Shroff","year":"2008","unstructured":"Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ, Singhal A, Merryweather I, Brogan P, Shanahan C, Deanfield J, Rees L (2008) The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 23:3263\u20133271","journal-title":"Nephrol Dial Transplant"},{"key":"4936_CR90","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00467-011-1870-5","volume":"26","author":"E Siomou","year":"2011","unstructured":"Siomou E, Challa A, Printza N, Giapros V, Petropoulou F, Mitsioni A, Papachristou F, Stefanidis CJ (2011) Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease. Pediatr Nephrol 26:1105\u20131114","journal-title":"Pediatr Nephrol"},{"key":"4936_CR91","doi-asserted-by":"publisher","first-page":"e0166792","DOI":"10.1371\/journal.pone.0166792","volume":"11","author":"CS Kim","year":"2016","unstructured":"Kim CS, Bae EH, Ma SK, Han SH, Choi KH, Lee J, Chae DW, Oh KH, Ahn C, Kim SW, Representatives of the KNOW-CKD Investigator Group (2016) Association of serum osteoprotegerin levels with bone loss in chronic kidney disease: insights from the KNOW-CKD study. PLoS One 11:e0166792","journal-title":"PLoS One"},{"key":"4936_CR92","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1440-1797.2011.01481.x","volume":"16","author":"JQ Jiang","year":"2011","unstructured":"Jiang JQ, Lin S, Xu PC, Zheng ZF, Jia JY (2011) Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder. Nephrology (Carlton) 16:588\u2013594","journal-title":"Nephrology (Carlton)"},{"key":"4936_CR93","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/08860220500198698","volume":"27","author":"A Crisafulli","year":"2005","unstructured":"Crisafulli A, Romeo A, Floccari F, Aloisi E, Atteritano M, Cincotta M, Aloisi C, Pizzolio M, Ruello A, Artemisia A, Valenti A, Frisina N, Teti D, Buemi M (2005) Osteoprotegerin and bone mineral density in hemodiafiltration patients. Ren Fail 27:531\u2013539","journal-title":"Ren Fail"},{"key":"4936_CR94","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ndt\/gfr316","volume":"27","author":"ML Ford","year":"2012","unstructured":"Ford ML, Smith ER, Tomlinson LA, Chatterjee PK, Rajkumar C, Holt SG (2012) FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease,mineral bone disorder and the heart. Nephrol Dial Transplant 27:727\u2013733","journal-title":"Nephrol Dial Transplant"},{"key":"4936_CR95","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/bonekey.2016.48","volume":"5","author":"H Kaji","year":"2016","unstructured":"Kaji H (2016) Effects of myokines on bone. Bonekey Rep 5:826","journal-title":"Bonekey Rep"},{"key":"4936_CR96","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41390-019-0278-y","volume":"85","author":"G Colaianni","year":"2019","unstructured":"Colaianni G, Faienza MF, Sanesi L, Brunetti G, Pignataro P, Lippo L, Bortolotti S, Storlino G, Piacente L, D'Amato G, Colucci S, Grano M (2019) Irisin serum levels are positively correlated with bone mineral status in a population of healthy children. Pediatr Res 85:484\u2013488","journal-title":"Pediatr Res"},{"key":"4936_CR97","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41467-017-01131-0","volume":"8","author":"MM Reza","year":"2017","unstructured":"Reza MM, Subramaniyam N, Sim CM, Ge X, Sathiakumar D, McFarlane C, Sharma M, Kambadur R (2017) Irisin is a pro-myogenic factor that induces skeletal muscle hypertrophy and rescues denervation-induced atrophy. Nat Commun 8:1104","journal-title":"Nat Commun"},{"key":"4936_CR98","doi-asserted-by":"publisher","first-page":"e64025","DOI":"10.1371\/journal.pone.0064025","volume":"8","author":"MS Wen","year":"2013","unstructured":"Wen MS, Wang CY, Lin SL, Hung KC (2013) Decrease in irisin in patients with chronic kidney disease. PLoS One 8:e64025","journal-title":"PLoS One"},{"key":"4936_CR99","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.nefro.2016.05.019","volume":"36","author":"A Rodr\u00edguez-Carmona","year":"2016","unstructured":"Rodr\u00edguez-Carmona A, P\u00e9rez Font\u00e1n M, Sangiao Alvarellos S, Garc\u00eda Falc\u00f3n T, Pena Bello ML, L\u00f3pez Mu\u00f1iz A, Cordido F (2016) Serum levels of the adipomyokine irisin in patients with chronic kidney disease. Nefrologia 36:496\u2013502","journal-title":"Nefrologia"},{"key":"4936_CR100","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1055\/s-0033-1354402","volume":"45","author":"C Moraes","year":"2013","unstructured":"Moraes C, Leal VO, Marinho SM, Barroso SG, Rocha GS, Boaventura GT, Mafra D (2013) Resistance exercise training does not affect plasma irisin levels of hemodialysis patients. Horm Metab Res 45:900\u2013904","journal-title":"Horm Metab Res"},{"key":"4936_CR101","doi-asserted-by":"publisher","first-page":"e0176137","DOI":"10.1371\/journal.pone.0176137","volume":"12","author":"Z Tan","year":"2017","unstructured":"Tan Z, Ye Z, Zhang J, Chen Y, Cheng C, Wang C, Liu X, Lou T, Peng H (2017) Serum irisin levels correlated to peritoneal dialysis adequacy in nondiabetic peritoneal dialysis patients. PLoS One 12:e0176137","journal-title":"PLoS One"},{"key":"4936_CR102","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1159\/000485925","volume":"42","author":"SJ Zhou","year":"2017","unstructured":"Zhou SJ, Han QF, Zhang AH, Tang W, Sun LH (2017) Irisin and volume overload are associated with protein energy wasting in peritoneal dialysis patients. Kidney Blood Press Res 42:1216\u20131224","journal-title":"Kidney Blood Press Res"},{"key":"4936_CR103","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.atherosclerosis.2015.08.002","volume":"242","author":"MJ Lee","year":"2015","unstructured":"Lee MJ, Lee SA, Nam BY, Park S, Lee SH, Ryu HJ, Kwon YE, Kim YL, Park KS, Oh HJ, Park JT, Han SH, Ryu DR, Kang SW, Yoo TH (2015) Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients. Atherosclerosis 242:476\u2013482","journal-title":"Atherosclerosis"},{"key":"4936_CR104","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000443412","volume":"41","author":"WY He","year":"2016","unstructured":"He WY, Wu F, Pang XX, Chen GJ, LT A, He L, Wang S, Tang CS, Zhang AH (2016) Irisin is associated with urotensin II and protein energy wasting in hemodialysis patients. Kidney Blood Press Res 41:78\u201385","journal-title":"Kidney Blood Press Res"},{"key":"4936_CR105","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1530\/EJE-13-1053","volume":"170","author":"T Ebert","year":"2014","unstructured":"Ebert T, Focke D, Petroff D, Wurst U, Richter J, Bachmann A, L\u00f6ssner U, Kralisch S, Kratzsch J, Beige J, Bast I, Anders M, Bl\u00fcher M, Stumvoll M, Fasshauer M (2014) Serum levels of the myokine irisin in relation to metabolic and renal function. Eur J Endocrinol 170:501\u2013506","journal-title":"Eur J Endocrinol"},{"key":"4936_CR106","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000487689","volume":"43","author":"L He","year":"2018","unstructured":"He L, He WY, LT A, Yang WL, Zhang AH (2018) Lower serum Irisin levels are associated with increased vascular calcification in hemodialysis patients. Kidney Blood Press Res 43:287\u2013295","journal-title":"Kidney Blood Press Res"},{"key":"4936_CR107","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1210\/jc.2018-02216","volume":"104","author":"A Palermo","year":"2019","unstructured":"Palermo A, Sanesi L, Colaianni G, Tabacco G, Naciu AM, Cesareo R, Pedone C, Lelli D, Brunetti G, Mori G, Colucci S, Manfrini S, Napoli N, Grano M (2019) A novel interplay between irisin and PTH: from basic studies to clinical evidence in hyperparathyroidism. J Clin Endocrinol Metab 104:3088\u20133096","journal-title":"J Clin Endocrinol Metab"},{"key":"4936_CR108","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s13539-011-0035-5","volume":"2","author":"Y Elkina","year":"2011","unstructured":"Elkina Y, von Haehling S, Anker SD, Springer J (2011) The role of myostatin in muscle wasting: an overview. J Cachexia Sarcopenia Muscle 2:143\u2013151","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4936_CR109","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.bbrc.2015.07.018","volume":"464","author":"A Retamales","year":"2015","unstructured":"Retamales A, Zuloaga R, Valenzuela CA, Gallardo-Escarate C, Molina A, Vald\u00e9s JA (2015) Insulin-like growth factor-1 suppresses the myostatin signaling pathway during myogenic differentiation. Biochem Biophys Res Commun 464:596\u2013602","journal-title":"Biochem Biophys Res Commun"},{"key":"4936_CR110","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1210\/en.2010-0488","volume":"152","author":"NG Williams","year":"2011","unstructured":"Williams NG, Interlichia JP, Jackson MF, Hwang D, Cohen P, Rodgers BD (2011) Endocrine actions of myostatin: systemic regulation of the IGF and IGF binding protein axis. Endocrinology 152:172\u2013180","journal-title":"Endocrinology"},{"key":"4936_CR111","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1530\/JOE-17-0032","volume":"234","author":"A Hennebry","year":"2017","unstructured":"Hennebry A, Oldham J, Shavlakadze T, Grounds MD, Sheard P, Fiorotto ML, Falconer S, Smith HK, Berry C, Jeanplong F, Bracegirdle J, Matthews K, Nicholas G, Senna-Salerno M, Watson T, McMahon CD (2017) IGF1 stimulates greater muscle hypertrophy in the absence of myostatin in male mice. J Endocrinol 234:187\u2013200","journal-title":"J Endocrinol"},{"key":"4936_CR112","doi-asserted-by":"publisher","first-page":"e0141035","DOI":"10.1371\/journal.pone.0141035","volume":"10","author":"S Yano","year":"2015","unstructured":"Yano S, Nagai A, Isomura M, Yamasaki M, Kijima T, Takeda M, Hamano T, Nabika T (2015) Relationship between blood myostatin levels and kidney function:Shimane CoHRE study. PLoS One 10:e0141035","journal-title":"PLoS One"},{"key":"4936_CR113","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/ki.2010.494","volume":"79","author":"D Verzola","year":"2011","unstructured":"Verzola D, Procopio V, Sofia A, Villaggio B, Tarroni A, Bonanni A, Mannucci I, De Cian F, Gianetta E, Saffioti S, Garibotto G (2011) Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease. Kidney Int 79:773\u2013782","journal-title":"Kidney Int"},{"key":"4936_CR114","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.kint.2018.10.010","volume":"95","author":"D Verzola","year":"2019","unstructured":"Verzola D, Barisione C, Picciotto D, Garibotto G, Koppe L (2019) Emerging role of myostatin and its inhibition in the setting of chronic kidney disease. Kidney Int 95:506\u2013517","journal-title":"Kidney Int"},{"key":"4936_CR115","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1365-2265.2011.04120.x","volume":"75","author":"DS Han","year":"2011","unstructured":"Han DS, Chen YM, Lin SY, Chang HH, Huang TM, Chi YC, Yang WS (2011) Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis. Clin Endocrinol 75:857\u2013863","journal-title":"Clin Endocrinol"},{"key":"4936_CR116","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1365-2265.2011.04225.x","volume":"75","author":"RH Mak","year":"2011","unstructured":"Mak RH (2011) Serum myostatin in patients on maintenance haemodialysis: a useful biomarker of muscle wasting? Clin Endocrinol 75:738\u2013789","journal-title":"Clin Endocrinol"},{"key":"4936_CR117","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1096\/fj.10-176917","volume":"25","author":"L Zhang","year":"2011","unstructured":"Zhang L, Rajan V, Lin E, Hu Z, Han HQ, Zhou X, Song Y, Min H, Wang X, Du J, Mitch WE (2011) Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J 25:1653\u20131663","journal-title":"FASEB J"},{"key":"4936_CR118","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.kint.2016.07.039","volume":"91","author":"T Sugatani","year":"2017","unstructured":"Sugatani T, Agapova OA, Fang Y, Berman AG, Wallace JM, Malluche HH, Faugere MC, Smith W, Sung V, Hruska KA (2017) Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease. Kidney Int 91:86\u201395","journal-title":"Kidney Int"},{"key":"4936_CR119","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.ki.5001532","volume":"70","author":"DF Sun","year":"2006","unstructured":"Sun DF, Chen Y, Rabkin R (2006) Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia. Kidney Int 70:453\u2013459","journal-title":"Kidney Int"},{"key":"4936_CR120","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/ndt\/gfx065","volume":"32","author":"R Shroff","year":"2017","unstructured":"Shroff R, Wan M, Nagler EV, Bakkaloglu S, Fischer DC, Bishop N, Cozzolino M, Bacchetta J, Edefonti A, Stefanidis CJ, Vande Walle J, Haffner D, Klaus G, Schmitt CP, European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders and Dialysis Working Groups (2017) Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease stages 2-5 and on dialysis. Nephrol Dial Transplant 32:1098\u20131113","journal-title":"Nephrol Dial Transplant"},{"key":"4936_CR121","first-page":"313","volume":"76","author":"A Tahar","year":"2018","unstructured":"Tahar A, Zerdoumi F, Saidani M, Griene L, Koceir EA (2018) Effects of oral vitamin D3 supplementation in stage 3 chronic kidney disease subjects: insulin resistance syndrome and hormonal disturb interactions. Ann Biol Clin (Paris) 76:313\u2013325","journal-title":"Ann Biol Clin (Paris)"},{"key":"4936_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08860220500461187","volume":"28","author":"RP Mathur","year":"2006","unstructured":"Mathur RP, Dash SC, Gupta N, Prakash S, Saxena S, Bhowmik D (2006) Effects of correction of metabolic acidosis on blood urea and bone metabolism in patients with mild to moderate chronic kidney disease: a prospective randomized single blind controlled trial. Ren Fail 28:1\u20135","journal-title":"Ren Fail"},{"key":"4936_CR123","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1172\/JCI108962","volume":"61","author":"E McSherry","year":"1978","unstructured":"McSherry E, Morris RC (1978) Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. J Clin Invest 61:509\u2013527","journal-title":"J Clin Invest"},{"key":"4936_CR124","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1046\/j.1523-1755.2002.00656.x","volume":"62","author":"S Domrongkitchaiporn","year":"2002","unstructured":"Domrongkitchaiporn S, Pongskul C, Sirikulchayanonta V, Stitchantrakul W, Leeprasert V, Ongphiphadhanakul B, Radinahamed P, Rajatanavin R (2002) Bone histology and bone mineral density after correction of acidosis in distal renal tubular acidosis. Kidney Int 62:2160\u20132166","journal-title":"Kidney Int"},{"key":"4936_CR125","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1093\/ndt\/12.12.2633","volume":"12","author":"AJ Williams","year":"1997","unstructured":"Williams AJ, Dittmer ID, McArley A, Clarke J (1997) High bicarbonate dialysate in haemodialysis patients: effects on acidosis and nutritional status. Nephrol Dial Transplant 12:2633\u20132637","journal-title":"Nephrol Dial Transplant"},{"key":"4936_CR126","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2215\/CJN.08340812","volume":"8","author":"MK Abramowitz","year":"2013","unstructured":"Abramowitz MK, Melamed ML, Bauer C, Raff AC, Hostetter TH (2013) Effects of oral sodium bicarbonate in patients with CKD. Clin J Am Soc Nephrol 8:714\u2013720","journal-title":"Clin J Am Soc Nephrol"},{"key":"4936_CR127","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1681\/ASN.2008111205","volume":"20","author":"I De Brito-Ashurst","year":"2009","unstructured":"De Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM (2009) Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 20:2075\u20132084","journal-title":"J Am Soc Nephrol"},{"key":"4936_CR128","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s004670000340","volume":"14","author":"A Hokken-Koelega","year":"2000","unstructured":"Hokken-Koelega A, Mulder P, De Jong R, Lilien M, Donckerwolcke R, Groothof J (2000) Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Pediatr Nephrol 14:701\u2013706","journal-title":"Pediatr Nephrol"},{"key":"4936_CR129","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1046\/j.1365-2265.1998.00593.x","volume":"49","author":"AM Boot","year":"1998","unstructured":"Boot AM, Nauta J, de Jong MC, Groothoff JW, Lilien MR, van Wijk JA, Kist-van Holthe JE, Hokken-Koelega AC, Pols HA, de Muinck Keizer-Schrama SM (1998) Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment. Clin Endocrinol 49:665\u2013672","journal-title":"Clin Endocrinol"},{"key":"4936_CR130","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s004670000470","volume":"15","author":"IM van der Sluis","year":"2000","unstructured":"van der Sluis IM, Boot AM, Nauta J, Hop WC, de Jong MC, Lilien MR, Groothoff JW, van Wijk AE, Pols HA, Hokken-Koelega AC, de Muinck Keizer-Schrama SM (2000) Bone density and body composition in chronic renal failure: effects of growth hormone treatment. Pediatr Nephrol 15:221\u2013228","journal-title":"Pediatr Nephrol"},{"key":"4936_CR131","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000185098","volume":"46","author":"R Lanes","year":"1996","unstructured":"Lanes R, Gunczler P, Orta N, Bosquez M, Scovino R, Dominguez L, Esaa S, Weisinger JR (1996) Changes in bone mineral density, growth velocity and renal function of prepubertal uremic children during growth hormone treatment. Horm Res Paediatr 46:263\u2013268","journal-title":"Horm Res Paediatr"},{"key":"4936_CR132","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s004670000342","volume":"14","author":"VL Johnson","year":"2000","unstructured":"Johnson VL, Wang J, Kaskel FJ, Pierson RN (2000) Changes in body composition of children with chronic renal failure on growth hormone. Pediatr Nephrol 14:695\u2013700","journal-title":"Pediatr Nephrol"},{"key":"4936_CR133","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.2215\/CJN.07791109","volume":"5","author":"F Santos","year":"2010","unstructured":"Santos F, Moreno ML, Neto A, Ariceta G, Vara J, Alonso A, Bueno A, Afonso AC, Correia AJ, Muley R, Barrios V, G\u00f3mez C, Argente J (2010) Improvement in growth after 1 year of growth hormone therapy in well-nourished infants with growth retardation secondary to chronic renal failure: results of a multicenter, controlled, randomized, open clinical trial. Clin J Am Soc Nephrol 5:1190\u20131197","journal-title":"Clin J Am Soc Nephrol"},{"key":"4936_CR134","doi-asserted-by":"publisher","first-page":"824","DOI":"10.2215\/CJN.00330112","volume":"8","author":"J Bacchetta","year":"2013","unstructured":"Bacchetta J, Wesseling-Perry K, Kuizon B, Pereira RC, Gales B, Wang HJ, Elashoff R, Salusky IB (2013) The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial. Clin J Am Soc Nephrol 8:824\u2013832","journal-title":"Clin J Am Soc Nephrol"},{"key":"4936_CR135","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1053\/j.ajkd.2012.12.010","volume":"61","author":"K Nawrot-Wawrzyniak","year":"2013","unstructured":"Nawrot-Wawrzyniak K, Misof BM, Roschger P, Pa\u0144czyk-Tomaszewska M, Zi\u00f3\u0142kowska H, Klaushofer K, Fratzl-Zelman N (2013) Changes in bone matrix mineralization after growth hormone treatment in children and adolescents with chronic kidney failure treated by dialysis: a paired biopsy study. Am J Kidney Dis 61:767\u2013777","journal-title":"Am J Kidney Dis"},{"key":"4936_CR136","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00467-014-2971-8","volume":"30","author":"KK Lau","year":"2015","unstructured":"Lau KK, Obeid J, Breithaupt P, Belostotsky V, Arora S, Nguyen T, Timmons BW (2015) Effects of acute exercise on markers of inflammation in pediatric chronic kidney disease: a pilot study. Pediatr Nephrol 30:615\u2013621","journal-title":"Pediatr Nephrol"},{"key":"4936_CR137","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00467-013-2675-5","volume":"29","author":"F Paglialonga","year":"2014","unstructured":"Paglialonga F, Lopopolo A, Scarfia RV, Consolo S, Galli MA, Salera S, Grassi MR, Brivio A, Edefonti A (2014) Intradialytic cycling in children and young adults on chronic hemodialysis. Pediatr Nephrol 29:431\u2013438","journal-title":"Pediatr Nephrol"},{"key":"4936_CR138","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00467-008-1079-4","volume":"24","author":"SL Goldstein","year":"2009","unstructured":"Goldstein SL, Montgomery LR (2009) A pilot study of twice-weekly exercise during hemodialysis in children. Pediatr Nephrol 24:833\u2013839","journal-title":"Pediatr Nephrol"},{"key":"4936_CR139","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00467-008-1015-7","volume":"24","author":"M van Bergen","year":"2009","unstructured":"van Bergen M, Takken T, Engelbert R, Groothoff J, Nauta J, van Hoeck K, Helders P, Lilien M (2009) Exercise training in pediatric patients with end-stage renal disease. Pediatr Nephrol 24:619\u2013622","journal-title":"Pediatr Nephrol"},{"key":"4936_CR140","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1519\/JSC.0000000000001374","volume":"30","author":"SM Marinho","year":"2016","unstructured":"Marinho SM, Moraes C, Barbosa JE, Carraro Eduardo JC, Fouque D, Pelletier S, Mafra D (2016) Exercise training alters the bone mineral density of hemodialysis patients. J Strength Cond Res 30:2918\u20132923","journal-title":"J Strength Cond Res"},{"key":"4936_CR141","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/ndt\/gfx342","volume":"33","author":"P Molina","year":"2018","unstructured":"Molina P, Vizca\u00edno B, Molina MD, Beltr\u00e1n S, Gonz\u00e1lez-Moya M, Mora A, Castro-Alonso C, Kanter J, \u00c1vila AI, G\u00f3rriz JL, Esta\u00f1 N, Pallard\u00f3 LM, Fouque D, Carrero JJ (2018) The effect of high-volume online haemodiafiltration on nutritional status and body composition: the ProtEin Stores prEservaTion (PESET) study. Nephrol Dial Transplant 33:1223\u20131235","journal-title":"Nephrol Dial Transplant"},{"key":"4936_CR142","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/08860220701392181","volume":"29","author":"J Ma\u0142yszko","year":"2007","unstructured":"Ma\u0142yszko J, Ma\u0142yszko JS, Ko\u017aminski P, Pawlak K, Wo\u0142czynski S, My\u015bliwiec M (2007) Markers of bone metabolism in hemodialyses and hemodiafiltration. Ren Fail 29:595\u2013601","journal-title":"Ren Fail"},{"key":"4936_CR143","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1093\/ndt\/gfh403","volume":"19","author":"M Fischbach","year":"2004","unstructured":"Fischbach M, Terzic J, Laugel V, Dheu C, Menouer S, Helms P, Livolsi A (2004) Daily on-line haemodiafiltration: a pilot trial in children. Nephrol Dial Transplant 19:2360\u20132367","journal-title":"Nephrol Dial Transplant"},{"key":"4936_CR144","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpeds.2010.06.036","volume":"158","author":"A Hoppe","year":"2011","unstructured":"Hoppe A, von Puttkamer C, Linke U, Kahler C, Booss M, Braunauer-Kolberg R, Hofmann K, Joachimsky P, Hirte I, Schley S, Utsch B, Thumfart J, Briese S, Gellermann J, Zimmering M, Querfeld U, M\u00fcller D (2011) A hospital-based intermittent nocturnal hemodialysis program for children and adolescents. J Pediatr 158:95\u201399","journal-title":"J Pediatr"},{"key":"4936_CR145","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/ndt\/gfp565","volume":"25","author":"M Fischbach","year":"2010","unstructured":"Fischbach M, Terzic J, Menouer S, Dheu C, Seuge L, Zalosczic A (2010) Daily on line haemodiafiltration promotes catch-up growth in children on chronic dialysis. Nephrol Dial Transplant 25:867\u2013887","journal-title":"Nephrol Dial Transplant"},{"key":"4936_CR146","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1681\/ASN.2018100990","volume":"30","author":"R Shroff","year":"2019","unstructured":"Shroff R, Smith C, Ranchin B, Bayazit AK, Stefanidis CJ, Askiti V, Azukaitis K, Canpolat N, A\u011fba\u015f A, Aitkenhead H, Anarat A, Aoun B, Aofolaju D, Bakkaloglu SA, Bhowruth D, Borzych-Du\u017ca\u0142ka D, Bulut IK, B\u00fcscher R, Deanfield J, Dempster C, Duzova A, Habbig S, Hayes W, Hegde S, Krid S, Licht C, Litwin M, Mayes M, Mir S, Nemec R, Obrycki L, Paglialonga F, Picca S, Samaille C, Shenoy M, Sinha MD, Spasojevic B, Stronach L, Vidal E, Vondr\u00e1k K, Yilmaz A, Zaloszyc A, Fischbach M, Schmitt CP, Schaefer F (2019) Effects of hemodiafiltration versus conventional hemodialysis in children with ESKD: the HDF, heart and height study. J Am Soc Nephrol 30:678\u2013691","journal-title":"J Am Soc Nephrol"},{"key":"4936_CR147","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00467-012-2258-x","volume":"28","author":"L Rees","year":"2013","unstructured":"Rees L, Jones H (2013) Nutritional management and growth in children with chronic kidney disease. Pediatr Nephrol 28:527\u2013536","journal-title":"Pediatr Nephrol"},{"key":"4936_CR148","doi-asserted-by":"publisher","first-page":"e0122691","DOI":"10.1371\/journal.pone.0122691","volume":"10","author":"S Yamamoto","year":"2015","unstructured":"Yamamoto S, Kido R, Onishi Y, Fukuma S, Akizawa T, Fukagawa M, Kazama JJ, Narita I, Fukuhara S (2015) Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients. PLoS One 10:e0122691","journal-title":"PLoS One"},{"key":"4936_CR149","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12882-019-1223-3","volume":"20","author":"YL Lin","year":"2019","unstructured":"Lin YL, Chen SY, Lai YH, Wang CH, Kuo CH, Liou HH, Hsu BG (2019) Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients. BMC Nephrol 20:54","journal-title":"BMC Nephrol"},{"key":"4936_CR150","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1172\/JCI125915","volume":"129","author":"N Bonnet","year":"2019","unstructured":"Bonnet N, Bourgoin L, Biver E, Douni E, Ferrari S (2019) RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest 129:3214\u20133223","journal-title":"J Clin Invest"},{"key":"4936_CR151","doi-asserted-by":"publisher","first-page":"962","DOI":"10.2215\/CJN.11031017","volume":"13","author":"P Khairallah","year":"2018","unstructured":"Khairallah P, Nickolas TL (2018) Management of osteoporosis in CKD. Clin J Am Soc Nephrol 13:962\u2013969","journal-title":"Clin J Am Soc Nephrol"},{"key":"4936_CR152","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1123\/ijsnem.2015-0337","volume":"26","author":"L Tang","year":"2016","unstructured":"Tang L, Gao X, Yang X, Zhang D, Zhang X, Du H, Han Y, Sun L (2016) Combination of weight-bearing training and anti-MSTN polyclonal antibody improve bone quality in rats. Int J Sport Nutr Exerc Metab 26:516\u2013524","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"4936_CR153","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000452150","volume":"86","author":"A Grimberg","year":"2016","unstructured":"Grimberg A, Di Vall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, Rossi WC, Feudtner C, Murad MH, Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society (2016) Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr 86:361\u2013397","journal-title":"Horm Res Paediatr"},{"key":"4936_CR154","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/ki.1996.199","volume":"49","author":"GT Kov\u00e1cs","year":"1996","unstructured":"Kov\u00e1cs GT, Oh J, Kov\u00e1cs J, T\u00f6nshoff B, Hunziker EB, Zapf J, Mehls O (1996) Growth promoting effects of growth hormone and IGF-I are additive in experimental uremia. Kidney Int 49:1413\u20131421","journal-title":"Kidney Int"},{"key":"4936_CR155","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41581-019-0161-4","volume":"15","author":"J Drube","year":"2019","unstructured":"Drube J, Wan M, Bonthuis M, W\u00fchl E, Bacchetta J, Santos F, Grenda R, Edefonti A, Harambat J, Shroff R, T\u00f6nshoff B, Haffner D, European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups (2019) Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol 15:577\u2013589","journal-title":"Nat Rev Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-04936-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-04936-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-04936-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T23:07:32Z","timestamp":1674947252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-04936-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":155,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4936"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-04936-w","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"assertion":[{"value":"28 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}